Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation

Journal of Neuroimmune Pharmacology

Volumn 5, Issue 3, 2010, Pages 278-293

  Shah, Sonia ^a   Nonnemacher, Michael R ^a   Pirrone, Vanessa ^a   Wigdahl, Brian ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

HIV 1; immune factors; latency; transcription

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; CYTOKINE; GAMMA INTERFERON; INTEGRASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 27; INTERLEUKIN 6; INTERLEUKIN 7; PROTEINASE; RNA DIRECTED DNA POLYMERASE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; DISEASE CARRIER; EPIGENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; LATENT PERIOD; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; REVIEW; VIRUS GENOME; VIRUS INFECTION;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; EPIGENESIS, GENETIC; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; IMMUNITY, INNATE; VIRUS ACTIVATION; VIRUS INTEGRATION; VIRUS LATENCY;

EID: 77955984711     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-010-9207-x     Document Type: Review

References (188)

1. L Al-Harthi KA Roebuck A Landay 1998 Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production J Clin Immunol 18 124 131 1:CAS:528:DyaK1cXitFemu70%3D
2. AV Albright RM Vos F Gonzalez-Scarano 2004 Low-level HIV replication in mixed glial cultures is associated with alterations in the processing of p55(Gag) Virology 325 328 339 1:CAS:528:DC%2BD2cXls1WksLo%3D
3. TM Alce W Popik 2004 APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein J Biol Chem 279 34083 34086 1:CAS:528:DC%2BD2cXmvFensbk%3D
4. A Alexaki B Wigdahl 2008 HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination PLoS Pathog 4 e1000215
5. A Alexaki Y Liu B Wigdahl 2008 Cellular reservoirs of HIV-1 and their role in viral persistence Curr HIV Res 6 388 400 1:CAS:528:DC%2BD1cXhtlWgu7bL
6. M Alfano A Crotti E Vicenzi G Poli 2008 New players in cytokine control of HIV infection Curr HIV/AIDS Rep 5 27 32
7. G Alter M Altfeld 2009 NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection J Intern Med 265 29 42 1:CAS:528:DC%2BD1MXhvFCjs7Y%3D
8. SF An M Groves F Gray F Scaravilli 1999 Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals J Neuropathol Exp Neurol 58 1156 1162 1:STN:280: DC%2BD3c%2Fitleitg%3D%3D
9. NM Archin KS Keedy A Espeseth H Dang DJ Hazuda DM Margolis 2009 Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors AIDS 23 1799 1806 1:CAS:528: DC%2BD1MXhtVCnsrbK
10. M Barboric RM Nissen S Kanazawa N Jabrane-Ferrat BM Peterlin 2001 NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II Mol Cell 8 327 337 1:CAS:528:DC%2BD3MXmvFWgsbc%3D
11. SD Barr J Leipzig P Shinn JR Ecker FD Bushman 2005 Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome J Virol 79 12035 12044 1:CAS:528:DC%2BD2MXhtVWktLzJ
12. B Berkhout KT Jeang 1992 Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat J Virol 66 139 149 1:CAS:528: DyaK38Xlt1ymsw%3D%3D
13. B Berkhout A Gatignol AB Rabson KT Jeang 1990 TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter Cell 62 757 767 1:CAS:528:DyaK3cXlsVKhtb4%3D
14. C Berry S Hannenhalli J Leipzig FD Bushman 2006 Selection of target sites for mobile DNA integration in the human genome PLoS Comput Biol 2 e157
15. P Biswas G Poli AL Kinter JS Justement SK Stanley WJ Maury P Bressler JM Orenstein AS Fauci 1992 Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells J Exp Med 176 739 750 1:CAS:528:DyaK38XlsV2itbY%3D
16. P Biswas G Poli JM Orenstein AS Fauci 1994 Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? J Virol 68 2598 2604 1:CAS:528: DyaK2cXisVagtr4%3D
17. D Boden O Pusch F Lee L Tucker B Ramratnam 2003 Human immunodeficiency virus type 1 escape from RNA interference J Virol 77 11531 11535 1:CAS:528:DC%2BD3sXosFSjurw%3D
18. R Brack-Werner A Kleinschmidt A Ludvigsen W Mellert M Neumann R Herrmann MC Khim A Burny N Muller-Lantzsch D Stavrou, et al. 1992 Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines AIDS 6 273 285 1:STN:280:DyaK383jt1WmsA%3D%3D
19. T Brady LM Agosto N Malani CC Berry U O'Doherty F Bushman 2009 HIV integration site distributions in resting and activated CD4+ T cells infected in culture AIDS 23 1461 1471
20. MI Bukrinsky TL Stanwick MP Dempsey M Stevenson 1991 Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection Science 254 423 427 1:CAS:528:DyaK3MXmslOrsLc%3D
21. MI Bukrinsky N Sharova MP Dempsey TL Stanwick AG Bukrinskaya S Haggerty M Stevenson 1992 Active nuclear import of human immunodeficiency virus type 1 preintegration complexes Proc Natl Acad Sci U S A 89 6580 6584 1:STN:280:DyaK38zjsFensA%3D%3D
22. TH Burdo S Gartner D Mauger B Wigdahl 2004 Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients J Neurovirol 10 Suppl 1 7 14 1:CAS:528:DC%2BD2cXhsFajtro%3D
23. TH Burdo M Nonnemacher BP Irish CH Choi FC Krebs S Gartner B Wigdahl 2004 High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia DNA Cell Biol 23 261 269 1:CAS:528: DC%2BD2cXjsVGjsrs%3D
24. JC Burnett K Miller-Jensen PS Shah AP Arkin DV Schaffer 2009 Control of stochastic gene expression by host factors at the HIV promoter PLoS Pathog 5 e1000260
25. F Bushman M Lewinski A Ciuffi S Barr J Leipzig S Hannenhalli C Hoffmann 2005 Genome-wide analysis of retroviral DNA integration Nat Rev Microbiol 3 848 858 1:CAS:528:DC%2BD2MXhtFKlt7nJ
26. AA Byrnes DM Harris SF Atabani BP Sabundayo SJ Langan JB Margolick CL Karp 2008 Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy J Leukoc Biol 84 1447 1453 1:CAS:528:DC%2BD1cXhsVKhsrbE
27. A Cereseto L Manganaro MI Gutierrez M Terreni A Fittipaldi M Lusic A Marcello M Giacca 2005 Acetylation of HIV-1 integrase by p300 regulates viral integration EMBO J 24 3070 3081 1:CAS:528:DC%2BD2MXpslelu7c%3D
28. K Chen J Huang C Zhang S Huang G Nunnari FX Wang X Tong L Gao K Nikisher H Zhang 2006 Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells J Virol 80 7645 7657 1:CAS:528:DC%2BD28XnsVWgtbg%3D
29. C Cheng-Mayer C Weiss D Seto JA Levy 1989 Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus Proc Natl Acad Sci U S A 86 8575 8579 1:STN:280: DyaK3c%2Fks1ynsg%3D%3D
30. TW Chun D Finzi J Margolick K Chadwick D Schwartz RF Siliciano 1995 In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency Nat Med 1 1284 1290 1:CAS:528:DyaK2MXpslGhtbg%3D
31. TW Chun L Carruth D Finzi X Shen JA DiGiuseppe H Taylor M Hermankova K Chadwick J Margolick TC Quinn YH Kuo R Brookmeyer MA Zeiger P Barditch-Crovo RF Siliciano 1997 Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection Nature 387 183 188 1:CAS:528:DyaK2sXjtF2gtr8%3D
32. TW Chun D Engel SB Mizell CW Hallahan M Fischette S Park RT Davey Jr M Dybul JA Kovacs JA Metcalf JM Mican MM Berrey L Corey HC Lane AS Fauci 1999 Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy Nat Med 5 651 655 1:CAS:528:DyaK1MXjs1Kmu7s%3D
33. GA Coburn BR Cullen 2002 Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference J Virol 76 9225 9231 1:CAS:528:DC%2BD38XmslCjt78%3D
34. JM Coffin 1995 HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Science 267 483 489 1:CAS:528: DyaK2MXjsFShu7w%3D
35. CM Coleman L Wu 2009 HIV interactions with monocytes and dendritic cells: viral latency and reservoirs Retrovirology 6 51
36. MA Cosenza ML Zhao Q Si SC Lee 2002 Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis Brain Pathol 12 442 455 1:CAS:528:DC%2BD38Xot1Gns7g%3D
37. JJ Coull F Romerio JM Sun JL Volker KM Galvin JR Davie Y Shi U Hansen DM Margolis 2000 The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1 J Virol 74 6790 6799 1:CAS:528:DC%2BD3cXkvFCmtrc%3D
38. F d'Adda di Fagagna G Marzio MI Gutierrez LY Kang A Falaschi M Giacca 1995 Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1 J Virol 69 2765 2775
39. LE Davis BL Hjelle VE Miller DL Palmer AL Llewellyn TL Merlin SA Young RG Mills W Wachsman CA Wiley 1992 Early viral brain invasion in iatrogenic human immunodeficiency virus infection Neurology 42 1736 1739 1:STN:280: DyaK38zot1Oluw%3D%3D
40. F Demarchi P D'Agaro A Falaschi M Giacca 1993 In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 J Virol 67 7450 7460 1:CAS:528:DyaK2cXkslaksQ%3D%3D
41. L Deng D Wang C de la Fuente L Wang H Li CG Lee R Donnelly JD Wade P Lambert F Kashanchi 2001 Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA Virology 289 312 326 1:CAS:528:DC%2BD3MXnvFGhs78%3D
42. TL Diamond M Roshal VK Jamburuthugoda HM Reynolds AR Merriam KY Lee M Balakrishnan RA Bambara V Planelles S Dewhurst B Kim 2004 Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase J Biol Chem 279 51545 51553 1:CAS:528:DC%2BD2cXhtVaqs7vJ
43. C Dong C Kwas L Wu 2009 Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes J Virol 83 3518 3527 1:CAS:528:DC%2BD1MXktlSjtbc%3D
44. LC Edelstein S Micheva-Viteva BD Phelan JP Dougherty 2009 Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma AIDS Res Hum Retroviruses 25 883 887 1:CAS:528:DC%2BD1MXhtFars7jM
45. A Engelman K Mizuuchi R Craigie 1991 HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer Cell 67 1211 1221 1:CAS:528:DyaK38XksVCnsL8%3D
46. L Fan K Peden 1992 Cell-free transmission of Vif mutants of HIV-1 Virology 190 19 29 1:CAS:528:DyaK38XlvVyju7o%3D
47. CM Farnet FD Bushman 1997 HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro Cell 88 483 492 1:CAS:528:DyaK2sXhtlKqu7s%3D
48. R Festenstein SN Pagakis K Hiragami D Lyon A Verreault B Sekkali D Kioussis 2003 Modulation of heterochromatin protein 1 dynamics in primary mammalian cells Science 299 719 721 1:CAS:528:DC%2BD3sXntFWhsw%3D%3D
49. D Finzi M Hermankova T Pierson LM Carruth C Buck RE Chaisson TC Quinn K Chadwick J Margolick R Brookmeyer J Gallant M Markowitz DD Ho DD Richman RF Siliciano 1997 Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy Science 278 1295 1300 1:CAS:528:DyaK2sXntlOmsro%3D
50. D Finzi J Blankson JD Siliciano JB Margolick K Chadwick T Pierson K Smith J Lisziewicz F Lori C Flexner TC Quinn RE Chaisson E Rosenberg B Walker S Gange J Gallant RF Siliciano 1999 Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy Nat Med 5 512 517 1:CAS:528:DyaK1MXivVKksro%3D
51. T Fischer-Smith S Croul A Adeniyi K Rybicka S Morgello K Khalili J Rappaport 2004 Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy Am J Pathol 164 2089 2099 1:CAS:528:DC%2BD2cXltFymsLo%3D
52. TM Folks J Justement A Kinter S Schnittman J Orenstein G Poli AS Fauci 1988 Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate J Immunol 140 1117 1122 1:CAS:528:DyaL1cXhsVyltrk%3D
53. TM Folks SW Kessler JM Orenstein JS Justement ES Jaffe AS Fauci 1988 Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow Science 242 919 922 1:STN:280:DyaL1M%2Fktl2luw%3D%3D
54. C Fraser NM Ferguson AC Ghani JM Prins JM Lange J Goudsmit RM Anderson F de Wolf 2000 Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs AIDS 14 659 669 1:CAS:528:DC%2BD3cXjtlKlt74%3D
55. F Gao DL Robertson SG Morrison H Hui S Craig J Decker PN Fultz M Girard GM Shaw BH Hahn PM Sharp 1996 The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin J Virol 70 7013 7029 1:CAS:528:DyaK28XlslWjs70%3D
56. ME Gerritsen AJ Williams AS Neish S Moore Y Shi T Collins 1997 CREB-binding protein/p300 are transcriptional coactivators of p65 Proc Natl Acad Sci U S A 94 2927 2932 1:CAS:528:DyaK2sXisVKgsLc%3D
57. M Gomez-Gonzalo M Carretero J Rullas E Lara-Pezzi J Aramburu B Berkhout J Alcami M Lopez-Cabrera 2001 The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter J Biol Chem 276 35435 35443 1:CAS:528: DC%2BD3MXntFahsr8%3D
58. EV Granowitz BM Saget MZ Wang CA Dinarello PR Skolnik 1995 Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1 Mol Med 1 667 677 1:CAS:528:DyaK2MXpsVClsrY%3D
59. AT Haase 1986 The AIDS lentivirus connection Microb Pathog 1 1 4 1:STN:280:DyaL1M3jslOrsA%3D%3D
60. Y Han M Wind-Rotolo HC Yang JD Siliciano RF Siliciano 2007 Experimental approaches to the study of HIV-1 latency Nat Rev Microbiol 5 95 106 1:CAS:528:DC%2BD2sXkslCgsQ%3D%3D
61. D Harrich J Garcia R Mitsuyasu R Gaynor 1990 TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes EMBO J 9 4417 4423 1:CAS:528:DyaK3MXht1Sjt7g%3D
62. A Harris NE Bolus 2008 HIV/AIDS: an update Radiol Technol 79 243 252 quiz 253-245
63. G He DM Margolis 2002 Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat Mol Cell Biol 22 2965 2973 1:CAS:528:DC%2BD38XivFylsb4%3D
64. U Heider J Rademacher B Lamottke M Mieth M Moebs I von Metzler C Assaf O Sezer 2009 Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma Eur J Haematol 82 440 449 1:CAS:528:DC%2BD1MXmtVyls70%3D
65. AJ Henderson KL Calame 1997 CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells Proc Natl Acad Sci U S A 94 8714 8719 1:CAS:528:DyaK2sXltlWhsbw%3D
66. AJ Henderson X Zou KL Calame 1995 C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes J Virol 69 5337 5344 1:CAS:528:DyaK2MXns1Kit7k%3D
67. AJ Henderson RI Connor KL Calame 1996 C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines Immunity 5 91 101 1:CAS:528:DyaK28Xks1Omur4%3D
68. KW Henry A Wyce WS Lo LJ Duggan NC Emre CF Kao L Pillus A Shilatifard MA Osley SL Berger 2003 Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8 Genes Dev 17 2648 2663 1:CAS:528:DC%2BD3sXovVaht7Y%3D
69. WF Hickey K Vass H Lassmann 1992 Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras J Neuropathol Exp Neurol 51 246 256 1:STN:280:DyaK383mtValuw%3D%3D
70. DD Ho TR Rota MS Hirsch 1986 Infection of monocyte/macrophages by human T lymphotropic virus type III J Clin Invest 77 1712 1715 1:STN:280: DyaL287ps1OgsQ%3D%3D
71. DD Ho AU Neumann AS Perelson W Chen JM Leonard M Markowitz 1995 Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 123 126 1:CAS:528:DyaK2MXjtFSrt7o%3D
72. JE Hoberg AE Popko CS Ramsey MW Mayo 2006 IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300 Mol Cell Biol 26 457 471 1:CAS:528:DC%2BD28XhtVOhsbo%3D
73. TH Hogan MR Nonnemacher FC Krebs A Henderson B Wigdahl 2003 HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific Biomed Pharmacother 57 41 48 1:CAS:528:DC%2BD3sXitV2hsrg%3D
74. TH Hogan DL Stauff FC Krebs S Gartner SJ Quiterio B Wigdahl 2003 Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression J Neurovirol 9 55 68 1:CAS:528:DC%2BD3sXitVCmtr0%3D
75. C Holscher A Holscher D Ruckerl T Yoshimoto H Yoshida T Mak C Saris S Ehlers 2005 The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis J Immunol 174 3534 3544
76. K Ikeda K Nagano K Kawakami 1993 Possible implications of Sp1-induced bending of DNA on synergistic activation of transcription Gene 136 341 343 1:CAS:528:DyaK2cXht1Krurc%3D
77. K Imai T Okamoto 2006 Transcriptional repression of human immunodeficiency virus type 1 by AP-4 J Biol Chem 281 12495 12505 1:CAS:528:DC%2BD28XjvFKksLY%3D
78. T Imamichi J Yang DW Huang TW Brann BA Fullmer JW Adelsberger RA Lempicki MW Baseler HC Lane 2008 IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages AIDS 22 39 45 1:CAS:528: DC%2BD2sXhsVequrnK
79. JM Jacque K Triques M Stevenson 2002 Modulation of HIV-1 replication by RNA interference Nature 418 435 438 1:CAS:528:DC%2BD38XlsFajtrk%3D
80. G Jiang A Espeseth DJ Hazuda DM Margolis 2007 c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter J Virol 81 10914 10923 1:CAS:528:DC%2BD2sXhtFelt73P
81. P Joel W Shao K Pratt 1993 A nuclear protein with enhanced binding to methylated Sp1 sites in the AIDS virus promoter Nucleic Acids Res 21 5786 5793 1:CAS:528:DyaK2cXpvVWqsg%3D%3D
82. KA Jones BM Peterlin 1994 Control of RNA initiation and elongation at the HIV-1 promoter Annu Rev Biochem 63 717 743 1:CAS:528:DyaK2MXitlCgsA%3D%3D
83. A Jordan P Defechereux E Verdin 2001 The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation EMBO J 20 1726 1738 1:CAS:528:DC%2BD3MXivVCrs74%3D
84. A Jordan D Bisgrove E Verdin 2003 HIV reproducibly establishes a latent infection after acute infection of T cells in vitro EMBO J 22 1868 1877 1:CAS:528:DC%2BD3sXivFCjur4%3D
85. K Kaehlcke A Dorr C Hetzer-Egger V Kiermer P Henklein M Schnoelzer E Loret PA Cole E Verdin M Ott 2003 Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation Mol Cell 12 167 176
86. SE Kauder A Bosque A Lindqvist V Planelles E Verdin 2009 Epigenetic regulation of HIV-1 latency by cytosine methylation PLoS Pathog 5 e1000495
87. RE Kiernan C Vanhulle L Schiltz E Adam H Xiao F Maudoux C Calomme A Burny Y Nakatani KT Jeang M Benkirane C Van Lint 1999 HIV-1 tat transcriptional activity is regulated by acetylation EMBO J 18 6106 6118 1:CAS:528: DyaK1MXns1ent78%3D
88. YK Kim CF Bourgeois R Pearson M Tyagi MJ West J Wong SY Wu CM Chiang J Karn 2006 Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency EMBO J 25 3596 3604 1:CAS:528:DC%2BD28XnvVGlsLc%3D
89. AL Kinter SM Bende EC Hardy R Jackson AS Fauci 1995 Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression Proc Natl Acad Sci U S A 92 10985 10989 1:CAS:528:DyaK2MXps1alsr0%3D
90. SA Klein C Klebba D Kauschat M Pape L Ozmen D Hoelzer OG Ottmann U Kalina 2000 Interleukin-18 stimulates HIV-1 replication in a T-cell line Eur Cytokine Netw 11 47 52 1:CAS:528:DC%2BD3cXitlylsL0%3D
91. KK Koelsch L Liu R Haubrich S May D Havlir HF Gunthard CC Ignacio P Campos-Soto SJ Little R Shafer GK Robbins RT D'Aquila Y Kawano K Young P Dao CA Spina DD Richman JK Wong 2008 Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro J Infect Dis 197 411 419
92. M Koot IP Keet AH Vos RE de Goede MT Roos RA Coutinho F Miedema PT Schellekens M Tersmette 1993 Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS Ann Intern Med 118 681 688 1:STN:280:DyaK3s3htlSjtA%3D%3D
93. YD Korin JA Zack 1999 Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes J Virol 73 6526 6532 1:CAS:528:DyaK1MXksFKntL4%3D
94. S Kramer-Hammerle I Rothenaigner H Wolff JE Bell R Brack-Werner 2005 Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus Virus Res 111 194 213
95. K Lassen Y Han Y Zhou J Siliciano RF Siliciano 2004 The multifactorial nature of HIV-1 latency Trends Mol Med 10 525 531 1:CAS:528:DC%2BD2cXptFKktbo%3D
96. H Lassmann M Schmied K Vass WF Hickey 1993 Bone marrow derived elements and resident microglia in brain inflammation Glia 7 19 24 1:STN:280: DyaK3s7jvVOguw%3D%3D
97. G Lehrman IB Hogue S Palmer C Jennings CA Spina A Wiegand AL Landay RW Coombs DD Richman JW Mellors JM Coffin RJ Bosch DM Margolis 2005 Depletion of latent HIV-1 infection in vivo: a proof-of-concept study Lancet 366 549 555 1:CAS:528:DC%2BD2MXns1Wgsrk%3D
98. J Leonard C Parrott AJ Buckler-White W Turner EK Ross MA Martin AB Rabson 1989 The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity J Virol 63 4919 4924 1:CAS:528:DyaL1MXmt1Kit7k%3D
99. MK Lewinski D Bisgrove P Shinn H Chen C Hoffmann S Hannenhalli E Verdin CC Berry JR Ecker FD Bushman 2005 Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription J Virol 79 6610 6619 1:CAS:528:DC%2BD2MXksFKhtbg%3D
100. MK Lewinski M Yamashita M Emerman A Ciuffi H Marshall G Crawford F Collins P Shinn J Leipzig S Hannenhalli CC Berry JR Ecker FD Bushman 2006 Retroviral DNA integration: viral and cellular determinants of target-site selection PLoS Pathog 2 e60
101. HG Lim K Suzuki DA Cooper AD Kelleher 2008 Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro Mol Ther 16 565 570 1:CAS:528:DC%2BD1cXisFOkurs%3D
102. MK Liszewski JJ Yu U O'Doherty 2009 Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR Methods 47 254 260 1:CAS:528: DC%2BD1MXltFWgtbk%3D
103. JW Maciaszek NA Parada WW Cruikshank DM Center H Kornfeld GA Viglianti 1997 IL-16 represses HIV-1 promoter activity J Immunol 158 5 8 1:CAS:528:DyaK2sXhtlalsQ%3D%3D
104. N Madani D Kabat 2000 Cellular and viral specificities of human immunodeficiency virus type 1 vif protein J Virol 74 5982 5987 1:CAS:528:DC%2BD3cXkt1eiur4%3D
105. EZ Managlia A Landay L Al-Harthi 2006 Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway Virology 350 443 452 1:CAS:528: DC%2BD28Xmt1GktLk%3D
106. A Marcello 2006 Latency: the hidden HIV-1 challenge Retrovirology 3 7
107. HM Marshall K Ronen C Berry M Llano H Sutherland D Saenz W Bickmore E Poeschla FD Bushman 2007 Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting PLoS One 2 e1340
108. G Marzio M Giacca 1999 Chromatin control of HIV-1 gene expression Genetica 106 125 130 1:CAS:528:DC%2BD3cXpt1yrtQ%3D%3D
109. G Marzio M Tyagi MI Gutierrez M Giacca 1998 HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter Proc Natl Acad Sci U S A 95 13519 13524 1:CAS:528:DyaK1cXnsVGhtr8%3D
110. JJ McAllister D Phillips S Millhouse J Conner T Hogan HL Ross B Wigdahl 2000 Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication Virology 274 262 277 1:CAS:528:DC%2BD3cXmtVGmurY%3D
111. MJ McElrath JE Pruett ZA Cohn 1989 Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections Proc Natl Acad Sci U S A 86 675 679 1:STN:280: DyaL1M%2FpvV2qsQ%3D%3D
112. JE Merrill Y Koyanagi IS Chen 1989 Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor J Virol 63 4404 4408 1:CAS:528:DyaL1MXlvFartbg%3D
113. MD Miller CM Farnet FD Bushman 1997 Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition J Virol 71 5382 5390 1:CAS:528:DyaK2sXjvVKrsrc%3D
114. RS Mitchell BF Beitzel AR Schroder P Shinn H Chen CC Berry JR Ecker FD Bushman 2004 Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences PLoS Biol 2 E234
115. JK Nicholson GD Cross CS Callaway JS McDougal 1986 In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy- associated virus (HTLV-III/LAV) J Immunol 137 323 329 1:STN:280: DyaL283isFGmsQ%3D%3D
116. C Nielsen C Pedersen JD Lundgren J Gerstoft 1993 Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection AIDS 7 1035 1040 1:STN:280:DyaK2c%2FgtVGgsw%3D%3D
117. MR Nonnemacher BP Irish Y Liu D Mauger B Wigdahl 2004 Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progression J Neuroimmunol 157 39 47 1:CAS:528:DC%2BD2cXhtVaqsLvO
118. WA O'Brien 1994 HIV-1 entry and reverse transcription in macrophages J Leukoc Biol 56 273 277
119. A Oliva AL Kinter M Vaccarezza A Rubbert A Catanzaro S Moir J Monaco L Ehler S Mizell R Jackson Y Li JW Romano AS Fauci 1998 Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro J Clin Invest 102 223 231 1:CAS:528:DyaK1cXktlWktr4%3D
120. P Paci R Carello M Bernaschi G D'Offizi F Castiglione 2009 Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy BMC Infect Dis 9 172
121. FJ Palella Jr KM Delaney AC Moorman MO Loveless J Fuhrer GA Satten DJ Aschman SD Holmberg 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 853 860
122. MJ Pazin PL Sheridan K Cannon Z Cao JG Keck JT Kadonaga KA Jones 1996 NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro Genes Dev 10 37 49 1:CAS:528:DyaK28Xjslyruw%3D%3D
123. R Peluso A Haase L Stowring M Edwards P Ventura 1985 A Trojan Horse mechanism for the spread of visna virus in monocytes Virology 147 231 236 1:STN:280:DyaL28%2FksF2ruw%3D%3D
124. G Peng KJ Lei W Jin T Greenwell-Wild SM Wahl 2006 Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity J Exp Med 203 41 46 1:CAS:528:DC%2BD28XhtVyruro%3D
125. G Peng T Greenwell-Wild S Nares W Jin KJ Lei ZG Rangel PJ Munson SM Wahl 2007 Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression Blood 110 393 400 1:CAS:528:DC%2BD2sXnsVait7o%3D
126. ND Perkins LK Felzien JC Betts K Leung DH Beach GJ Nabel 1997 Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator Science 275 523 527 1:CAS:528:DyaK2sXnvVeksg%3D%3D
127. TC Pierson Y Zhou TL Kieffer CT Ruff C Buck RF Siliciano 2002 Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection J Virol 76 8518 8531 1:CAS:528:DC%2BD38Xmt1ertLo%3D
128. M Pion A Jordan A Biancotto F Dequiedt F Gondois-Rey S Rondeau R Vigne J Hejnar E Verdin I Hirsch 2003 Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation J Virol 77 4025 4032 1:CAS:528:DC%2BD3sXisVKku7s%3D
129. G Poli P Bressler A Kinter E Duh WC Timmer A Rabson JS Justement S Stanley AS Fauci 1990 Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms J Exp Med 172 151 158 1:CAS:528:DyaK3cXksFOhsbY%3D
130. JM Prins S Jurriaans RM van Praag H Blaak R van Rij PT Schellekens IJ ten Berge SL Yong CH Fox MT Roos F de Wolf J Goudsmit H Schuitemaker JM Lange 1999 Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy AIDS 13 2405 2410 1:CAS:528: DC%2BD3cXit1Kkug%3D%3D
131. ME Quinones-Mateu A Mas T Lain de Lera V Soriano J Alcami MM Lederman E Domingo 1998 LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression Virus Res 57 11 20 1:CAS:528: DyaK1cXmslOmtL4%3D
132. AR Rodriguez BP Arulanandam VL Hodara HM McClure EK Cobb MT Salas R White KK Murthy 2007 Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees J Gen Virol 88 641 651 1:CAS:528:DC%2BD2sXhsFars74%3D
133. EK Ross AJ Buckler-White AB Rabson G Englund MA Martin 1991 Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types J Virol 65 4350 4358 1:CAS:528:DyaK3MXltVOgsbs%3D
134. HL Ross S Gartner JC McArthur JR Corboy JJ McAllister S Millhouse B Wigdahl 2001 HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity J Neurovirol 7 235 249 1:CAS:528:DC%2BD3MXlvFaisLY%3D
135. HL Ross MR Nonnemacher TH Hogan SJ Quiterio A Henderson JJ McAllister FC Krebs B Wigdahl 2001 Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage J Virol 75 1842 1856 1:CAS:528:DC%2BD3MXhtVSns7w%3D
136. AR Schroder P Shinn H Chen C Berry JR Ecker F Bushman 2002 HIV-1 integration in the human genome favors active genes and local hotspots Cell 110 521 529 1:CAS:528:DC%2BD38Xmslyjt7g%3D
137. W Shao 1997 Characterization of HMBP-2, a DNA-binding protein that binds to HIV-1 LTR when only one of the three Sp1 sites is methylated J Biomed Sci 4 39 46 1:CAS:528:DyaK2sXjtFSmu74%3D
138. L Shapiro AJ Puren HA Barton D Novick RL Peskind R Shenkar Y Gu MS Su CA Dinarello 1998 Interleukin 18 stimulates HIV type 1 in monocytic cells Proc Natl Acad Sci U S A 95 12550 12555 1:CAS:528:DyaK1cXmsl2qtrg%3D
139. AM Sheehy NC Gaddis JD Choi MH Malim 2002 Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418 646 650 1:CAS:528:DC%2BD38XlvVyltLs%3D
140. AM Sheehy NC Gaddis MH Malim 2003 The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat Med 9 1404 1407 1:CAS:528:DC%2BD3sXosFOlurc%3D
141. Y Shirazi PM Pitha 1992 Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle J Virol 66 1321 1328 1:CAS:528:DyaK38Xht1KlsLY%3D
142. JD Siliciano J Kajdas D Finzi TC Quinn K Chadwick JB Margolick C Kovacs SJ Gange RF Siliciano 2003 Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells Nat Med 9 727 728 1:CAS:528:DC%2BD3sXktFOnu7k%3D
143. JD Siliciano J Lai M Callender E Pitt H Zhang JB Margolick JE Gallant J Cofrancesco Jr RD Moore SJ Gange RF Siliciano 2007 Stability of the latent reservoir for HIV-1 in patients receiving valproic acid J Infect Dis 195 833 836 1:CAS:528:DC%2BD2sXjvVSisr0%3D
144. JH Simon NC Gaddis RA Fouchier MH Malim 1998 Evidence for a newly discovered cellular anti-HIV-1 phenotype Nat Med 4 1397 1400 1:CAS:528:DyaK1cXnvVOju7w%3D
145. MK Singh CD Pauza 1992 Extrachromosomal human immunodeficiency virus type 1 sequences are methylated in latently infected U937 cells Virology 188 451 458 1:CAS:528:DyaK38Xkt1Cmu7o%3D
146. ST Smale 2003 The establishment and maintenance of lymphocyte identity through gene silencing Nat Immunol 4 607 615 1:CAS:528:DC%2BD3sXkvVKqtbg%3D
147. DJ Steger JL Workman 1997 Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer EMBO J 16 2463 2472 1:CAS:528: DyaK2sXjsV2ms7k%3D
148. HJ Stellbrink J van Lunzen M Westby E O'Sullivan C Schneider A Adam L Weitner B Kuhlmann C Hoffmann S Fenske PS Aries O Degen C Eggers H Petersen F Haag HA Horst K Dalhoff C Mocklinghoff N Cammack K Tenner-Racz P Racz 2002 Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial) AIDS 16 1479 1487 1:CAS:528:DC%2BD38XmsValt7Y%3D
149. M Suyama E Daikoku T Goto K Sano Y Morikawa 2009 Reactivation from latency displays HIV particle budding at plasma membrane, accompanying CD44 upregulation and recruitment Retrovirology 6 63
150. K Suzuki T Shijuuku T Fukamachi J Zaunders G Guillemin D Cooper A Kelleher 2005 Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region J RNAi Gene Silencing 1 66 78 1:CAS:528:DC%2BD2MXhtF2lurfN
151. K Suzuki T Juelich H Lim T Ishida T Watanebe DA Cooper S Rao AD Kelleher 2008 Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region J Biol Chem 283 23353 23363 1:CAS:528:DC%2BD1cXpvFGgtrw%3D
152. K Takahashi SL Wesselingh DE Griffin JC McArthur RT Johnson JD Glass 1996 Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry Ann Neurol 39 705 711 1:CAS:528: DyaK28Xkt1OmsLY%3D
153. VM Tesmer A Rajadhyaksha J Babin M Bina 1993 NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1 Proc Natl Acad Sci U S A 90 7298 7302 1:CAS:528:DyaK3sXms1eqtb0%3D
154. C Tornatore R Chandra JR Berger EO Major 1994 HIV-1 infection of subcortical astrocytes in the pediatric central nervous system Neurology 44 3 Pt 1 481 487 1:STN:280:DyaK2c7psFGjsA%3D%3D
155. G Trillo-Pazos A Diamanturos L Rislove T Menza W Chao P Belem S Sadiq S Morgello L Sharer DJ Volsky 2003 Detection of HIV-1 DNA in microglia/ macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection Brain Pathol 13 144 154 1:CAS:528:DC%2BD3sXjsF2gur0%3D
156. MJ Truong EC Darcissac E Hermann J Dewulf A Capron GM Bahr 1999 Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells J Virol 73 7008 7013 1:CAS:528:DyaK1MXksFKms7w%3D
157. BM Turner 1993 Decoding the nucleosome Cell 75 5 8 1:CAS:528:DyaK2cXhsFCq
158. M Tyagi J Karn 2007 CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency EMBO J 26 4985 4995 1:CAS:528:DC%2BD2sXhsVWhu7fK
159. K van Holde J Zlatanova 1996 What determines the folding of the chromatin fiber? Proc Natl Acad Sci U S A 93 10548 10555
160. C Van Lint S Emiliani M Ott E Verdin 1996 Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation EMBO J 15 1112 1120
161. C Van Lint CA Amella S Emiliani M John T Jie E Verdin 1997 Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity J Virol 71 6113 6127
162. B Van Maele K Busschots L Vandekerckhove F Christ Z Debyser 2006 Cellular co-factors of HIV-1 integration Trends Biochem Sci 31 98 105
163. RM van Praag JM Prins MT Roos PT Schellekens IJ Ten Berge SL Yong H Schuitemaker AJ Eerenberg S Jurriaans F de Wolf CH Fox J Goudsmit F Miedema JM Lange 2001 OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion J Clin Immunol 21 218 226
164. E Verdin 1991 DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1 J Virol 65 6790 6799 1:CAS:528:DyaK38Xhs1ej
165. E Verdin P Paras Jr C Van Lint 1993 Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation EMBO J 12 3249 3259 1:CAS:528:DyaK3sXlsFegsr8%3D
166. P Volberding L Demeter RJ Bosch E Aga C Pettinelli M Hirsch M Vogler A Martinez S Little E Connick 2009 Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment AIDS 23 1987 1995 1:CAS:528:DC%2BD1MXhtFamtrjJ
167. H von Briesen C von Mallinckrodt R Esser S Muller K Becker H Rubsamen-Waigmann R Andreesen 1991 Effect of cytokines and lipopolysaccharides on HIV infection of human macrophages Res Virol 142 197 204
168. Z Wang G Trillo-Pazos SY Kim M Canki S Morgello LR Sharer HA Gelbard ZZ Su DC Kang AI Brooks PB Fisher DJ Volsky 2004 Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis J Neurovirol 10 Suppl 1 25 32
169. FX Wang Y Xu J Sullivan E Souder EG Argyris EA Acheampong J Fisher M Sierra MM Thomson R Najera I Frank J Kulkosky RJ Pomerantz G Nunnari 2005 IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART J Clin Invest 115 128 137 1:CAS:528:DC%2BD2MXis1eruw%3D%3D
170. GP Wang A Ciuffi J Leipzig CC Berry FD Bushman 2007 HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications Genome Res 17 1186 1194 1:CAS:528: DC%2BD2sXptVyhsLs%3D
171. BA Watkins HH Dorn WB Kelly RC Armstrong BJ Potts F Michaels CV Kufta M Dubois-Dalcq 1990 Specific tropism of HIV-1 for microglial cells in primary human brain cultures Science 249 549 553 1:STN:280:DyaK3czktFOktQ%3D%3D
172. LS Weinberger JC Burnett JE Toettcher AP Arkin DV Schaffer 2005 Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity Cell 122 169 182 1:CAS:528: DC%2BD2MXntFGjs7s%3D
173. WHO/UNAIDS (2007) Joint United Nations Programme on HIV/AIDS/World Helath Organization AIDS epidemic update.
174. NL Wiech JF Fisher P Helquist O Wiest 2009 Inhibition of histone deacetylases: a pharmacological approach to the treatment of non-cancer disorders Curr Top Med Chem 9 257 271 1:CAS:528:DC%2BD1MXntVCitro%3D
175. CA Wiley RD Schrier JA Nelson PW Lampert MB Oldstone 1986 Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients Proc Natl Acad Sci U S A 83 7089 7093 1:STN:280:DyaL28zhtlOitw%3D%3D
176. KC Williams S Corey SV Westmoreland D Pauley H Knight C deBakker X Alvarez AA Lackner 2001 Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS J Exp Med 193 905 915 1:CAS:528:DC%2BD3MXivFOhtr8%3D
177. SA Williams LF Chen H Kwon CM Ruiz-Jarabo E Verdin WC Greene 2006 NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation EMBO J 25 139 149 1:CAS:528:DC%2BD28Xis1Kisw%3D%3D
178. SA Williams H Kwon LF Chen WC Greene 2007 Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1 J Virol 81 6043 6056 1:CAS:528:DC%2BD2sXmtFGks7o%3D
179. AP Wolffe 1994 Transcription: in tune with the histones Cell 77 13 16 1:CAS:528:DyaK2cXis1agtb8%3D
180. AP Wolffe D Pruss 1996 Targeting chromatin disruption: transcription regulators that acetylate histones Cell 84 817 819 1:CAS:528:DyaK28XhvFKjsr8%3D
181. JK Wong M Hezareh HF Gunthard DV Havlir CC Ignacio CA Spina DD Richman 1997 Recovery of replication-competent HIV despite prolonged suppression of plasma viremia Science 278 1291 1295 1:CAS:528:DyaK2sXntlOnu7k%3D
182. X Wu Y Li B Crise SM Burgess 2003 Transcription start regions in the human genome are favored targets for MLV integration Science 300 1749 1751 1:CAS:528:DC%2BD3sXksVKisL0%3D
183. M Yamagishi T Ishida A Miyake DA Cooper AD Kelleher K Suzuki T Watanabe 2009 Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription Microbes Infect 11 500 508 1:CAS:528:DC%2BD1MXkslyrsr8%3D
184. KE Yoder FD Bushman 2000 Repair of gaps in retroviral DNA integration intermediates J Virol 74 11191 11200 1:CAS:528:DC%2BD3MXitFWmtbY%3D
185. JA Zack SJ Arrigo SR Weitsman AS Go A Haislip IS Chen 1990 HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure Cell 61 213 222 1:STN:280:DyaK3c3jsFaksw%3D%3D
186. S Zhang D Pointer G Singer Y Feng K Park LJ Zhao 1998 Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1 Gene 212 157 166 1:CAS:528:DyaK1cXjvFSitLk%3D
187. Y Zhou H Zhang JD Siliciano RF Siliciano 2005 Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells J Virol 79 2199 2210 1:CAS:528:DC%2BD2MXitlejtLc%3D
188. T Zhu N Wang A Carr DS Nam R Moor-Jankowski DA Cooper DD Ho 1996 Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission J Virol 70 3098 3107 1:CAS:528:DyaK28Xit1Ohu70%3D